3 news items
S&P 500 Down Over 1%; US Retail Sales Increase 0.7% In March
LGVN
MRNS
NMRA
15 Apr 24
syndrome, a genetic disorder causing developmental disabilities and nerve-related symptoms.
Also Check This Out
Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session
ADIL
AEYE
ATHE
15 Apr 24
disorder causing developmental disabilities and nerve-related symptoms.
Ultragenyx Pharmaceutical shares dipped 9.4% to $42.46 on Monday
Crude Oil Down 1%; Charles Schwab Sales Top Estimates
LGVN
MRNS
NMRA
15 Apr 24
new data from the Phase 1/2 study of GTX-102 for Angelman syndrome, a genetic disorder causing developmental disabilities and nerve-related symptoms
- Prev
- 1
- Next